Symbiotec Pharmalab's IPO closed on August 27, subscribed 71 times overall, with strong demand from non-institutional investors and a grey market premium of Rs 270 per share.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.